Clinical TrialsSRD-002 Delivers Sustained 12-Month Improvements in HFpEF SRD-002 Delivers Sustained 12-Month Improvements in HFpEF Read Post »
Clinical TrialsZanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Zanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Read Post »
Clinical TrialsTaltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Taltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Read Post »
Clinical TrialsRepatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Repatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Read Post »
Clinical TrialsNew Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups New Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups Read Post »
Clinical TrialsKey QRX003 Interim Results Reveal Improvement in Netherton Syndrome Key QRX003 Interim Results Reveal Improvement in Netherton Syndrome Read Post »
Clinical TrialsCamzyos Shows Strong Five-Year Results in Patients With oHCM Camzyos Shows Strong Five-Year Results in Patients With oHCM Read Post »
Clinical TrialsCRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year CRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year Read Post »
Clinical TrialsAficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Read Post »
Clinical TrialsMiv-cel CAR T Therapy Shows Promise in Refractory RA Miv-cel CAR T Therapy Shows Promise in Refractory RA Read Post »
Clinical TrialsPaxalisib Shows Early Clinical Activity in Advanced TNBC Paxalisib Shows Early Clinical Activity in Advanced TNBC Read Post »
Clinical TrialsiECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... iECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... Read Post »
Clinical TrialsCorvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Corvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Read Post »
Clinical TrialsPositive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Positive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Read Post »
Clinical TrialsSpyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls ... Spyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls ... Read Post »
Clinical TrialsCan a New Cell-Based Transplant Repair Severe Eye Damage from Aniridia-Rela... Can a New Cell-Based Transplant Repair Severe Eye Damage from Aniridia-Rela... Read Post »
Clinical TrialsTRB-061 Shows Treg Activation and Expansion in Phase 1a Study, Supporting A... TRB-061 Shows Treg Activation and Expansion in Phase 1a Study, Supporting A... Read Post »
Clinical TrialsCelcuity Submits sNDA to FDA for REVTORPYK in PIK3CA-Mutant Advanced Breast... Celcuity Submits sNDA to FDA for REVTORPYK in PIK3CA-Mutant Advanced Breast... Read Post »
Clinical TrialsNeurocrine Gets FDA Clearance for Phase 2 NBI-1117567 Alzheimer’s Study Neurocrine Gets FDA Clearance for Phase 2 NBI-1117567 Alzheimer’s Study Read Post »
Clinical TrialsAriBio’s AR1005 Improves Cognitive Fluctuations in Interim Phase 2a D... AriBio’s AR1005 Improves Cognitive Fluctuations in Interim Phase 2a D... Read Post »
Clinical TrialsApollo Therapeutics Reports Positive Part A Immunogenicity Data for Pan-Rhi... Apollo Therapeutics Reports Positive Part A Immunogenicity Data for Pan-Rhi... Read Post »
Clinical TrialsLong-Term Real-World Data Show Sustained Disease Stabilization with Arimocl... Long-Term Real-World Data Show Sustained Disease Stabilization with Arimocl... Read Post »
Clinical TrialsRezpegaldesleukin Delivers Positive Phase 2b Results in Atopic Dermatitis, ... Rezpegaldesleukin Delivers Positive Phase 2b Results in Atopic Dermatitis, ... Read Post »
Clinical TrialsIvonescimab Plus Chemotherapy Extends Progression-Free Survival After Third... Ivonescimab Plus Chemotherapy Extends Progression-Free Survival After Third... Read Post »
Clinical TrialsInotuzumab Ozogamicin Shows 71% Response Rate in Children with Very High-Ri... Inotuzumab Ozogamicin Shows 71% Response Rate in Children with Very High-Ri... Read Post »
Clinical TrialsNovel Four-Drug Combination Shows Robust Activity Against Metastatic PDAC Novel Four-Drug Combination Shows Robust Activity Against Metastatic PDAC Read Post »
Clinical TrialsFDA Places Clinical Hold on REGENXBIO’s RGX-121 After Spine MRI Findings ... FDA Places Clinical Hold on REGENXBIO’s RGX-121 After Spine MRI Findings ... Read Post »
Clinical TrialsTrastuzumab Rezetecan Extends Progression-Free Survival to 30.6 Months in H... Trastuzumab Rezetecan Extends Progression-Free Survival to 30.6 Months in H... Read Post »
Clinical TrialsMazdutide Produces Up to 18.1% Weight Loss in US Phase 2 Obesity Trial Mazdutide Produces Up to 18.1% Weight Loss in US Phase 2 Obesity Trial Read Post »
Clinical TrialsBelzutifan-Lenvatinib Improves Progression-Free Survival in Previously Trea... Belzutifan-Lenvatinib Improves Progression-Free Survival in Previously Trea... Read Post »
Clinical TrialsCefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Cefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Read Post »
Clinical TrialsZalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Zalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Read Post »
Clinical TrialsMepolizumab Improves Disease Control and Moves Patients Toward Remission in... Mepolizumab Improves Disease Control and Moves Patients Toward Remission in... Read Post »
Clinical TrialsCan Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Can Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Read Post »
Clinical TrialsPositive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Positive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Read Post »
Clinical TrialsLeads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Leads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Read Post »
Clinical TrialsArcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Arcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Read Post »
Clinical TrialsModerna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Moderna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Read Post »
Clinical TrialsCould Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Could Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Read Post »
Clinical TrialsCan B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Can B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Read Post »
Clinical TrialsCan the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Can the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Read Post »
Clinical TrialsAvexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Avexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Read Post »
Clinical TrialsInnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... InnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... Read Post »
Clinical TrialsKRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... KRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... Read Post »
Clinical Trialsargenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... argenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... Read Post »
Clinical TrialsAstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... Read Post »
Clinical TrialsAstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... AstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... Read Post »
Clinical TrialsSecukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Secukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Read Post »
Clinical TrialsArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... ArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... Read Post »
Clinical TrialsClearmind Advances CMND-100 Trial into AUD After Positive Safety Review Clearmind Advances CMND-100 Trial into AUD After Positive Safety Review Read Post »
